“Maintenance Therapy for CD20+ Indolent Lymphoma: Who Should Receive Maintenance?”. Canadian Hematology Today, vol. 3, no. 1, Apr. 2024, pp. 44–50, https://doi.org/10.58931/cht.2024.3150.